Rezultati

eNauka >  Results >  Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
Title: Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
Authors: Smolen, Josef S; Pangan, Aileen L; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Vargas, Juan Ignacio; Zhang, Ying; Damjanov, Nemanja ; Friedman, Alan; Othman, Ahmed A;
Camp, Heidi S; Cohen, Stanley;
Issue Date: 2019
Publication: The Lancet
ISSN: 0140-6736 Lancet Search Idenfier
Type: Article
Collation: vol. 393 br. 10188 str. 2303-2311
DOI: 10.1016/s0140-6736(19)30419-2
WoS-ID: 000470263400027
Scopus-ID: 2-s2.0-85066764280
URI: https://enauka.gov.rs/handle/123456789/369569
Metadata source: Migrirano iz RIS podataka
M-category: 
21a+M21a+

322
SCOPUSTM
164
OpenCitations
320
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.